ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,168.93
0.80%
Dow Jones
38,787.66
0.29%
US Dollar vs MXN
16.8791
-0.62%
Brent Oil
83.395
0.32%
Bitcoin
63,274.29
-1.13%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Rigel Pharmaceuticals Inc (RIGL)

  7. Rigel Pharmaceuticals Inc (RIGL) Noticias

RIGL

Rigel Pharmaceuticals (RIGL)

Rigel Pharmaceuticals Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:RIGL
FechaHoraFuenteTítuloSímboloCompañía
30/04/202407:05PR Newswire (US)Rigel Announces Conference Call and Webcast to Report First Quarter 2024 Financial Results and Business UpdateNASDAQ:RIGLRigel Pharmaceuticals Inc
10/04/202415:30PR Newswire (US)Rigel Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)NASDAQ:RIGLRigel Pharmaceuticals Inc
04/04/202407:05PR Newswire (US)Rigel Announces Publication of Data on REZLIDHIA® (Olutasidenib) in Post-Venetoclax Patients with Mutant IDH1 AML in Leukemia & LymphomaNASDAQ:RIGLRigel Pharmaceuticals Inc
12/03/202407:05PR Newswire (US)Rigel Pharmaceuticals Announces Appointment of Lisa Rojkjaer, M.D. as Chief Medical OfficerNASDAQ:RIGLRigel Pharmaceuticals Inc
05/03/202415:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RIGLRigel Pharmaceuticals Inc
05/03/202415:06Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:RIGLRigel Pharmaceuticals Inc
05/03/202415:01PR Newswire (US)Rigel Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:RIGLRigel Pharmaceuticals Inc
01/03/202418:16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RIGLRigel Pharmaceuticals Inc
27/02/202407:05PR Newswire (US)Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Full Year 2023 Financial Results and Business UpdateNASDAQ:RIGLRigel Pharmaceuticals Inc
22/02/202406:50PR Newswire (US)Rigel Pharmaceuticals Acquires U.S. Rights to GAVRETO®NASDAQ:RIGLRigel Pharmaceuticals Inc
14/02/202413:30Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:RIGLRigel Pharmaceuticals Inc
08/01/202407:05PR Newswire (US)Rigel Pharmaceuticals Provides Business UpdateNASDAQ:RIGLRigel Pharmaceuticals Inc
04/01/202407:05PR Newswire (US)Rigel Announces Collaboration with CONNECT to Conduct a Phase 2 Trial of Olutasidenib in GliomaNASDAQ:RIGLRigel Pharmaceuticals Inc
03/01/202407:05PR Newswire (US)Rigel to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:RIGLRigel Pharmaceuticals Inc
08/12/202307:05PR Newswire (US)Rigel Pharmaceuticals and MD Anderson Announce Strategic Alliance to Advance REZLIDHIA® (Olutasidenib) in AML and Other CancersNASDAQ:RIGLRigel Pharmaceuticals Inc
07/11/202315:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RIGLRigel Pharmaceuticals Inc
07/11/202315:01PR Newswire (US)Rigel Reports Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:RIGLRigel Pharmaceuticals Inc
06/11/202307:05PR Newswire (US)Rigel to Present at the Jefferies London Healthcare ConferenceNASDAQ:RIGLRigel Pharmaceuticals Inc
02/11/202308:27PR Newswire (US)Rigel Announces Poster Presentations at the 65th American Society of Hematology Annual Meeting and ExpositionNASDAQ:RIGLRigel Pharmaceuticals Inc
31/10/202307:05PR Newswire (US)Rigel Announces Conference Call and Webcast to Report Third Quarter 2023 Financial Results and Business UpdateNASDAQ:RIGLRigel Pharmaceuticals Inc
11/10/202307:05PR Newswire (US)Rigel Announces Presentation at the Upcoming IDWeek 2023NASDAQ:RIGLRigel Pharmaceuticals Inc
20/09/202307:05PR Newswire (US)Rigel to Present at the 2023 Cantor Global Healthcare ConferenceNASDAQ:RIGLRigel Pharmaceuticals Inc
30/08/202307:05PR Newswire (US)Rigel to Participate in Upcoming September Investor ConferencesNASDAQ:RIGLRigel Pharmaceuticals Inc
01/08/202315:31Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:RIGLRigel Pharmaceuticals Inc
01/08/202315:01PR Newswire (US)Rigel Reports Second Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:RIGLRigel Pharmaceuticals Inc
25/07/202307:00PR Newswire (US)Rigel Announces Conference Call and Webcast to Report Second Quarter 2023 Financial Results and Business UpdateNASDAQ:RIGLRigel Pharmaceuticals Inc
05/07/202315:30PR Newswire (US)Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)NASDAQ:RIGLRigel Pharmaceuticals Inc
12/06/202307:22Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:RIGLRigel Pharmaceuticals Inc
07/06/202307:05PR Newswire (US)Rigel Announces Presentation of Data from Analysis of REZLIDHIA® (Olutasidenib) in Post-Venetoclax Patients with Mutant IDH1 AMLNASDAQ:RIGLRigel Pharmaceuticals Inc
06/06/202307:05PR Newswire (US)Rigel Announces Second REZLIDHIA® (Olutasidenib) Publication in Blood AdvancesNASDAQ:RIGLRigel Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:RIGL

Su Consulta Reciente

USOTC
BNPQY
BNP Paribas (QX)
COIN
SOLUSD
Solana
NYSE
AXP
American Express
SPI
SP500
S&P 500
FX
EURUSD
Euro vs US Dollar
NYSE
MCD
McDonalds
NYSE
NKE
Nike
NASDAQ
AMZN
Amazon.com
CCOM
US30
US 30
PM
XAUUSD
Gold vs US Dollar
NYSE
KO
Coca Cola
FX
USDMXN
US Dollar vs MXN
CCOM
OILBRENT
Brent Oil
USOTC
BASFY
BASF (QX)
NASDAQ
NVDA
NVIDIA
USOTC
RHHBY
Roche (QX)
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados